跳至主要内容
临床试验/ACTRN12621001721897
ACTRN12621001721897招募中未知

ImmuneCAP: Tissue-resident memory T cell response in severe community acquired pneumonia

The George Institute for Global Health0 个研究点目标入组 75 人开始时间: 2021年12月16日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Admitted to a critical care setting
  • A diagnosis of community acquired pneumonia has been made by the treating physicians
  • based on the following criteria;
  • - Symptoms and/or signs consistent with a lower respiratory tract infection
  • - Radiological evidence of new onset consolidation on a chest x-ray or CT scan
  • Mechanically ventilated for less than 72 hours
  • Age equal to or greater than 18 years old
  • Participant consent or person responsible consent
  • Patients with confirmed COVID-19 disease meeting the criteria for CAP will be included in

排除标准

  • Previously included in the study

研究者

相似试验